Hangzhou, China, September 28, 2023: The International Testing Agency (ITA), mandated by the Olympic Council of Asia (OCA) to independently handle areas of the anti-doping programme at the Asian Games Hangzhou 2022, including results management, reports that a sample collected from boxer Mohammad Khaibar Nooristani (Afghanistan) has returned an Adverse Analytical Finding 1* for the non-specified prohibited substances (i) 19-norandrosterone and (ii) Clostebol metabolite 4-chloro-3α-hydroxy-androst-4-en-17-one according to the Prohibited List of the World Anti-Doping Agency (WADA).
The sample was collected by the ITA under the testing authority and results management authority of the OCA at the Asian Games Hangzhou 2022 during an out-of-competition anti-doping control performed on 21 September 2023.
The athlete has been informed of the case and has been provisionally suspended with immediate effect. He has the right to request the analysis of the B sample.
The matter will thereafter be referred to the Anti-Doping Division of the Court of Arbitration for Sport for adjudication under the OCA Anti-Doping Rules.
Given that the case is underway, there will be no further comments during the ongoing proceeding.
*1 A report from a WADA-accredited laboratory that, consistent with the International Standard for Laboratories, establishes in a Sample the presence of a Prohibited Substance or its Metabolites or Markers or evidence of the Use of a Prohibited Method.